2211116-92-4
2211116-92-4
Chemical Structure
Adonertinib
Synonym(s): FHND9041
- CAS No.: 2211116-92-4
- Formula:C30H32D3N7O2
- Molecular Weight:528.66
InChIKey: CLXOEYRLLVMPJB-BMSJAHLVSA-N
SMILES: COC(C=C(C(NC(C=C)=O)=C1)N(C)CCN(C)C([2H])([2H])[2H])=C1NC2=NC=CC(C(C3=CC=C4)=CN5C3=C4CCC5)=N2
Biological Activity: Adonertinib (FHND9041) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, which is applicable to research related to advanced non-small cell lung cancer carrying EGFR-sensitive mutations[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Adonertinib | Adonertinib (FHND9041) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, which is applicable to research related to advanced non-small cell lung cancer carrying EGFR-sensitive mutations. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
